|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0033204,
umls-concept:C0138741,
umls-concept:C0201544,
umls-concept:C0376358,
umls-concept:C0439810,
umls-concept:C1096776,
umls-concept:C1274040,
umls-concept:C1366489,
umls-concept:C1417779,
umls-concept:C1516193,
umls-concept:C1527178,
umls-concept:C1705938,
umls-concept:C1880497,
umls-concept:C1996904
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-7-25
|
|
pubmed:abstractText |
The determination of the percentage of free prostate-specific antigen (%fPSA) enhances the specificity of prostate cancer (CaP) detection. This study was undertaken to assess the performance of %fPSA in differentiating benign prostate disease from CaP and to determine the CaP probability estimates using the AxSYM Free PSA and AxSYM Total PSA assays.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0090-4295
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
909-14
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays.
|
|
pubmed:affiliation |
University of Washington Medical School, Seattle, Washington 98195, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
